1 device · 1 company · 2022

Product code BXQ: Rhinoanemometer (Measurement Of Nasal Decongestion)

1 device under product code BXQ, 2022, from 1 company. Each record carries FDA's decision, the Indications for Use statement verbatim where the public document carries one (1 of 1 here), the regulation, and MAUDE report counts by product code.

Rhinoanemometer (Measurement Of Nasal Decongestion). 21 CFR 868.1800, Class II. MAUDE held 0 adverse-event reports against this product code as of 2026-10-29; reports are unverified and the code is shared by every device of this type.

Retrieved from FDA public records.

Every device, newest decision first

BXQ · 1 device
DecisionDeviceCompanyPanelFDA
VISIONAIRK221892 · 510(k)PacificMD Biotech LlcAnesthesiologydatabase entry

Every product code in the record, the whole record of FDA AI-enabled medical devices, or what Apodicta does on a medical record.

Show me on one of my files →

Every device here is authorized for a stated use. See a record read against what it must prove, on your own file.

Show me on my files